Clinical Trial Update: Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a chemotherapy-free combination of venetoclax, azacitidine, and orebatinib for newly diagnosed Philadelphia chromosome-posit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Orebatinib (orebatinib)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Ph-Positive Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING